Skip to main content
. 2019 Jun 3;26(1):299–307. doi: 10.1111/jep.13171

Figure 2.

Figure 2

Flow chart of the study patient. HbA1c, haemoglobin A1c; DPP4i, dipeptidyl peptidase‐4 inhibitor; BG, biguanide; SU, sulfonylurea; αGI, alpha glucosidase inhibitor; SGLT2 inhibitors, sodium glucose cotransporter 2 inhibitor; GLP‐1 agonist, glucagon‐like peptide‐1 receptor agonist